Clinical Trials in Baltimore

Showing 3241-3260 of 23,476 trials

Safety and Effectiveness of the Globe® Pulsed Field System for Treating Patients With Symptomatic Paroxysmal or Persistent Atrial Fibrillation

NCT05462145

This study will evaluate the safety and effectiveness of the Globe® Pulsed Field System for treating patients with symptomatic paroxysmal or persistent atrial fibrillation (AF).

Paroxysmal Atrial FibrillationPersistent Atrial Fibrillation

Kardium Inc.549 participantsStarted Mar 2023

Birmingham, Alabama, United States • Jonesboro, Arkansas, United States • San Francisco, California, United States +15 more locations

Active Not RecruitingPhase 3< 1 mile

A Study to Evaluate Safety and Efficacy of Ocrelizumab in Comparison With Fingolimod in Children and Adolescents With Relapsing-Remitting Multiple Sclerosis (RRMS)

NCT05123703

This double-blind, double-dummy study will evaluate the safety and efficacy of ocrelizumab compared with fingolimod in children and adolescents with RRMS aged between 10 and \< 18 years over a flexible duration. The double-blind period will last until after the last participant randomized has completed 24 weeks.

Relapsing-Remitting Multiple Sclerosis

Hoffmann-La Roche188 participantsStarted May 2022

La Jolla, California, United States • San Francisco, California, United States • Aurora, Colorado, United States +99 more locations

Safety and Effectiveness of the Globe® Pulsed Field System for Treating Patients With Symptomatic Paroxysmal or Persistent Atrial Fibrillation

A Study to Evaluate Safety and Efficacy of Ocrelizumab in Comparison With Fingolimod in Children and Adolescents With Relapsing-Remitting Multiple Sclerosis (RRMS)

Find Trials by Condition in Baltimore

A Study to Evaluate the Efficacy and Safety of ABC008 for Inclusion Body Myositis

OsteoPorotic fracTure preventION System (OPTIONS) Research Study

Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Breast Cancer

Prevention of Postpartum Hemorrhage With Tranexamic Acid

Assessing an Oral EGFR Inhibitor, Sunvozertinib in Patients Who Have Advanced Non-small Cell Lung Cancer With EGFR or HER2 Mutation (WU-KONG1)

Evaluation of Revumenib in Participants With Colorectal Cancer and Other Solid Tumors

A Study of PHN-010 in Patients With Advanced Solid Tumors

Study to Compare Efficacy, Safety, and Immunogenicity of LUBT010 (Proposed Ranibizumab Biosimilar) and Lucentis® in Patients With Neovascular AMD

TVMR With the INNOVALVE System Trial - Early Feasibility Study

TACE With or Without SBRT as Bridging Therapy for Pre-transplant HCC Patients

A Phase 1/2 Study to Evaluate CHM-2101, an Autologous Cadherin 17 Chimeric Antigen Receptor (CAR) T Cell Therapy

Phase III Study Assessing the Efficacy and Safety of Pegcetacoplan in Patients With C3 Glomerulopathy or Immune-Complex Membranoproliferative Glomerulonephritis

A Study in Patients Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab Study

Integrated Therapies for Alcohol Use in Alcohol-associated Liver Disease (ITAALD) Trial

Testing the Addition of the Anti-cancer Viral Therapy Telomelysin™ to Chemoradiation for Patients With Advanced Esophageal Cancer and Are Not Candidates for Surgery

A Study of Modakafusp Alfa Together With Daratumumab Adults With Relapsed or Refractory Multiple Myeloma

Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherapy in Advanced KRAS-Mutant Solid Tumours.

A Study With CIT-013 in HS Patients